HFT-012

N/A

Report date: 2025/01/26 18:42:26

Base Information

Drug NameHFT-012
Drug Alias Namedrag-reducing polymer (HemaFlo)HFT-012
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHemaFlo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHemaFlo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A